节点文献

抑制PPAR-α表达对ET-1诱导的心肌肥大和PI3K/Akt/GSK3β-NFATc4通路的影响

Effects of PPAR-α silence on ET-1 induced myocardial hypertrophy and PI3K/Akt/GSK3β-NFATc4 signal pathway

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 李瑞芳乐康高洁杨国庆鲍颖霞刘培庆

【Author】 LI Rui-fang2,LE Kang1,GAO Jie1,YANG Guo-qing1,BAO Ying-xia1,LIU Pei-qing1(1Laboratory of Pharmacology & Toxicology,School of Pharmaceutical Sciences,Sun Yat-sen University,Guangzhou 510080,China; 2Laboratory of Pharmacology,Medical College,Henan University of Science & Technology,Luoyang 471003,China. )

【机构】 河南科技大学医学院药理教研室中山大学药学院药理毒理实验室

【摘要】 目的:研究过氧化物酶体增殖物激活受体-α(PPAR-α)在病理性心肌肥大中的作用及其信号机制。方法:应用Invitrogen’s Stealth RNAi抑制心肌细胞PPAR-α的表达;采用[3H]-亮氨酸掺入法和RT-PCR检查心肌细胞蛋白质合成和心房利钠因子(ANF)mRNA的表达;采用Western blotting法检测Akt/GSK3β的磷酸化表达;应用免疫荧光技术检测NFATc4的胞核移位。结果:(1)RSS304168是最有效的PPAR-αRNAi,特异性地抑制了PPAR-α的表达。(2)非诺贝特预处理抑制了内皮素-1(ET-1)诱导的心肌细胞肥大(蛋白质合成和ANF mRNA的表达);RSS304168加强了ET-1的诱导效应,而且逆转了非诺贝特对心肌肥大的抑制效应。(3)非诺贝特降低了ET-1诱导的Akt/GSK3β的磷酸化表达,RSS304168增强了ET-1的诱导效应,ET-1和RSS304168的上述作用可被PI3K阻断剂LY294002所阻断;RSS304168逆转了非诺贝特对Akt/GSK3β的磷酸化表达的负性调控作用。(4)非诺贝特抑制了ET-1诱导的NFATc4的胞核移位;而RSS304168加强了ET-1的诱导作用,逆转了非诺贝特对NFATc4胞核移位的抑制作用。结论:PPAR-α激活可以通过PI3K/Akt/GSK3β-NFATc4通路抑制ET-1诱导的心肌肥大反应。

【Abstract】 AIM:To investigate the role and signal mechanism of PPAR-α in the pathogenesis of cardiac hypertrophy. METHODS:Small interfering RNA (siRNA) was applied to efficiently silence the gene expression of PPAR-α in cardiac myocytes. [3H] leucine incorporation assay was performed to measure protein synthesis. Reverse transcription-polymerase chain reaction (RT-PCR) was used to analyze the mRNA level of atrial natriuretic factor (ANF) and PPAR-α. Western blotting analysis was performed to investigate the levels of phosphorylation of protein kinase B (PKB/Akt) and glycogen synthase kinase 3β (GSK3β). Immunofluorescence analysis was used to examine the cellular localization of NFATc4. RESULTS:(1)RSS304168 was the most efficient stealth RNAi duplex to specifically inhibit PPAR-α expression. (2)RSS304168 significantly potentiated the ET-1-induced cardiomyocyte hypertrophy and enhanced ET-1-induced protein synthesis and ANF mRNA expression in cardiomyocytes. Moreover,RSS304168 completely reversed the inhibitory effects of fenofibrate on ET-1-induced protein synthesis and ANF mRNA expression. (3)RSS304168 enhanced ET-1-induced phosphorylation of Akt at Ser473 and GSK3β at Ser9. The effects of ET-1 or ET-1 combined with RSS304168 on phosphorylation of Akt/GSK3β were completely blocked by LY294002,a PI3K specific inhibitor. Fenofibrate markedly inhibited ET-1-induced phosphorylation of Akt/GSK3β while RSS304168 abolished these effects of fenofibrate. (4)Fenofibrate prevented the nuclear translocation of NFATc4 induced by ET-1 while RSS304168 abolished this effect of fenofibrate. CONCLUSION:Activation of PPAR-α inhibits ET-1-induced cardiomyocyte hypertrophy through blocking Akt/GSK3β-NFATc4 signaling pathways.

【基金】 国家自然科学基金资助项目(No.30772576);广东省自然科学基金重点资助项目(No.7117380)
  • 【文献出处】 中国病理生理杂志 ,Chinese Journal of Pathophysiology , 编辑部邮箱 ,2009年12期
  • 【分类号】R541
  • 【被引频次】11
  • 【下载频次】577
节点文献中: 

本文链接的文献网络图示:

本文的引文网络